Please login to the form below

Not currently logged in

Global Pricing Innovations and Partners4Access partner on market access

Will collaborate on orphan drug pricing and access solutions

Man Boobs campaign wins at D&AD Impact Awards

Takes home White Pencil in inaugural awards for creative contribution to society

Novartis says migraine prevention drug clears phase III trial

Novartis HQMonthly injection co-developed with Amgen could be launched in 2018


High Force Research launches STEM outreach programme

Appoints STEM coordinator to encourage students’ interest in the industry

Amgen takes aim at cardio diseases with Arrowhead RNAi deal

Amgen flagLicenses two gene silencing programmes with up to $670m in the offing for the specialist

Novo Nordisk to cut 1,000 jobs as diabetes competition builds

Novo Nordisk headquartersCites intensifying US market in particular for move to reduce costs

Bayer and Merck take high-risk heart failure drug into phase III

Bayer symbolEmbarks on final study of vericiguat despite it not meeting objectives in phase II trial

Boehringer buys into oncolytic viruses via €210m ViraTherapeutics deal

Option to acquire the Austrian biotech after phase I trials remains open to Boehringer

China: Smoking prevalence greater in men while women kick habit

China flag thumbNew study also finds the number of cigarettes smoked daily has risen

The global scourge of counterfeit medicines

Pharmaceuticals are a prime target for organised crime

  • Fair to medalling

    Generally competent at strategic planning, how can pharma transition from acceptable to exceptional to deliver gold standard performances?

  • Surviving Brexit

    How UK biopharma must adapt to a changing landscape

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Blog: Personality + creatives + sugar = an exciting branding project with the Young Dementia Network
Steve Hunt, Strategy Director for Ashfield Digital & Creative, recently had the opportunity to work on a really exciting and rewarding project with the Young Dementia Network, here he shares...
How merging firms can manage culture change
Addressing the potential problems and finding the solutions...
How to access and engage with HCPs effectively
HCP engagement requires the right mix of voice and content, plus knowledge of the channels to access, to reach the target audience...